Ifosfamide kit (10 vials (ifosfamide 1 GM in 20 mL Injection) / 10 vials (mesna 20 mg/ML in 10 mL)) Injectable Solution
RxNorm 899367

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 899367 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ifosfamide kit (10 vials (ifosfamide 1 GM in 20 mL Injection) / 10 vials (mesna 20 mg/ML in 10 mL)) Injectable Solution.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Ifosfamide kit (10 vials (ifosfamide 1 GM in 20 mL Injection) / 10 vials (mesna 20 mg/ML in 10 mL)) Injectable Solution
AUI:8220003
GPCK
{10 (20 mL ifosfamide 50 mg/ML Injection) / 10 (mesna 100 mg/ML Injectable Solution) } Pack
AUI:12372896
SY
{10 vials (ifosfamide 1 GM per 20 mL Injection) / 10 vials 10 mL (mesna 20 mg/ML (concentrate 100 mg/ML)) Injectable Solution} Kit
AUI:8220193

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSN

Prescribable Name (PSN):
Ifosfamide kit (10 vials (ifosfamide 1 GM in 20 mL Injection) / 10 vials (mesna 20 mg/ML in 10 mL)) Injectable Solution
(Atom ID: 8220003)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
ifosfamide kit (10 vials (ifosfamide 1 GM in 20 ML Injection) / 10 vials (mesna 20 MG/ML in 10 ML)) Injectable Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
899367
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8220003
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
899367
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

GPCK

Generic Pack (GPCK):
{10 (20 mL ifosfamide 50 mg/ML Injection) / 10 (mesna 100 mg/ML Injectable Solution) } Pack
(Atom ID: 12372896)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{10 (20 ML ifosfamide 50 MG/ML Injection) / 10 (mesna 100 MG/ML Injectable Solution) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
899367
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372896
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
899367
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
09/28/2022
Date the RxNorm atom became obsolete

SY

Synonym (SY):
{10 vials (ifosfamide 1 GM per 20 mL Injection) / 10 vials 10 mL (mesna 20 mg/ML (concentrate 100 mg/ML)) Injectable Solution} Kit
(Atom ID: 8220193)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{10 vials (ifosfamide 1 GM per 20 ML Injection) / 10 vials 10 ML (mesna 20 MG/ML (concentrate 100 MG/ML)) Injectable Solution} Kit
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
899367
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8220193
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
899367
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Ifosfamide Injection


Ifosfamide is used in combination with other medications to treat cancer of the testicles that has not improved or that has worsened after treatment with other medications or radiation therapy. Ifosfamide is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
[Learn More]


Mesna Injection


Mesna is used to reduce the risk of hemorrhagic cystitis (a condition that causes inflammation of the bladder and can result in serious bleeding) in people who receive ifosfamide (a medication used for the treatment of cancer). Mesna is in a class of medications called cytoprotectants. It works by protecting against some of the harmful effects of certain chemotherapy medications.
[Learn More]


Cancer Chemotherapy


Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.

You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.

Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).

NIH: National Cancer Institute


[Learn More]


* Please review the disclaimer below.